BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Deals

  China Rights To Isotechnika Pharma Inc.'s Transplant Drug Sold To 3SBio Inc. For US$6 Million

  August 25, 2010

   · 

  1 min read
• PharMerica Announces Share Repurchase Program

  August 25, 2010

   · 

  1 min read
• Business

  TiGenix Announces Spin-Out Of Its Targeted Drug Discovery Activities In New Company Arcarios

  August 25, 2010

   · 

  3 min read
• Policy

  Celgene’s Lead Drug Revlimid Faces Generic Challenge, Cites Notice on FDA Website

  August 25, 2010

   · 

  10 min read
• Drug Development

  Antigenics Inc. (Lexington, MA) Release: The Fourth Product Candidate Containing Antigenics’ QS-21 In Phase 3 Clinical Development

  August 25, 2010

   · 

  1 min read
• Drug Development

  FibroGen, Inc. Announces Results of 2-Year Study Demonstrating that Biosynthetic Corneas Formulated with Recombinant Human Type III Collagen Restore Vision and Promote Nerve Regeneration

  August 25, 2010

   · 

  1 min read
• e-Zassi Announces Capitalization and Commercialization RatingTM Service

  August 25, 2010

   · 

  1 min read
• Pharm Country

  CAS Medical Systems, Inc. Release: New Study Associates FORE-SIGHT Cerebral Oximetry With Lactate Flux in the Brain of Patients Undergoing Carotid Endarterectomy

  August 25, 2010

   · 

  1 min read
• Business

  BioAlliance: Consolidated Accounts for the First Semester of 2010

  August 25, 2010

   · 

  6 min read
• First Trimester Antiviral Drugs Acyclovir, Valacyclovir, and Famciclovir Not Linked to Birth Defects

  August 25, 2010

   · 

  1 min read